INDONESIA Situation

Coronavirus Report
Disease 201919 (COVID-19) World Health
World Health
Coronavirus Disease
Coronavirus Disease
Internal for SEARO
20192019 (COVID-19)
(COVID-19) Organization
Organization
SituationReport
Situation Report--716 Indonesia
Indonesia

Data Data
as of:
as 15 July
of 07 May2020
2020

HIGHLIGHTS
• As of 15 July, the Government of Indonesia
announced 80 094 confirmed cases of
COVID-19, 3 797 deaths and 39 050 recovered
cases from 463 districts across all 34 provinces1.

• The fifth revision of the national guidelines on

COVID-19 prevention and control was
finalized on 13 July. The updated patient
discharge criteria from the WHO guidance
have been adopted (page 5).

• WHO has published a scientific brief on

‘Transmission of SARS-CoV-2: implications for
infection prevention precautions’ which is
being translated into Indonesian to be widely
shared (pages 14-15).

Figure 1: Geographic distribution of cumulative number of confirmed COVID-19 cases in Indonesia across the
provinces reported between 09 to 15 July 2020. Source of data

Disclaimer: The number of cases reported daily is not equivalent to the number of persons who contracted
COVID-19 on that day; reporting of laboratory-confirmed results may take up to one week from the time of testing.

1
https://infeksiemerging.kemkes.go.id/
1
WHO Indonesia Situation Report - 16
who.int/indonesia
 GENERAL UPDATES

• On 09 July, there were 2 657 new confirmed cases of COVID-19 which is

the highest number reported on a single day since the beginning of the
pandemic. Out of those, a cluster of 1 280 people were from the Indonesian
Army Officer Candidate School in West Java: 991 cadets and the rest staff
and their family members. The Governor of West Java expressed regrets
about the outbreak and urged residents to restrict their movements in and
out of the neighbourhood where the academy is located until the outbreak
is brought under control2.

• The Governor of Jakarta, Anies Baswedan, stated that he will apply an

‘emergency brake policy’ and stop the transitional large-scale social
restrictions (PSBB) if Jakarta sees an uncontrollable number of confirmed
COVID-19 cases (if the daily number of infections double). He elaborated
that in the past two weeks Jakarta has recorded three of its highest single-
day surges in confirmed COVID-19 cases: on 05 July with 256 new
confirmed cases, then 11 July with 359 and 12 July with 404 new infections.
He demanded the public to strictly implement the predetermined
government health protocols: wearing a face mask anywhere, anytime
during any activity; maintaining a safe distance of at least one metre from
others; and frequently washing hands with soap and water3.

• The European Union (EU) has signed three grant agreements worth 86
billion Indonesian Rupiah (approximately US$ 6 million) with European and
Indonesian NGOs working in partnership to help Indonesia contain the
COVID-19 epidemic and its social and economic consequences. The
projects aim to respond to the immediate health crisis and the resulting
humanitarian needs of marginalized and high-risk populations;
strengthening health, water and sanitation systems, as well as the country’s
capacity and preparedness to deal with the pandemic; mitigating the
immediate social and economic consequences on vulnerable populations,
including supporting the private sector with a focus on small and medium-
sized enterprises; and government reforms to reduce poverty4.

2
https://www.straitstimes.com/asia/se-asia/nearly-1300-test-positive-for-virus-at-indonesian-military-
academy
3
https://en.tempo.co/read/1364425/anies-baswedan-to-stop-transitional-psbb-if-necessary
4
https://en.antaranews.com/news/152210/eu-signs-agreements-worth-rp86-billion-to-help-indonesia-
on-covid-19
2
WHO Indonesia Situation Report - 16
who.int/indonesia
 SURVEILLANCE
• On 15 July, 1 522 new and 80 094 cumulative confirmed COVID-19 cases
were reported (Fig. 2). The average for the last seven days was 1 716 cases
per day, compared to 1 473 per day for the previous seven days.

3000 90000

80000
2500
70000

Cumulative number
2000 60000
Daily number

50000
1500
40000

1000 30000

20000
500
10000

0 0
6-May
1-May
1-Apr
6-Apr

5-Jun

5-Jul
2-Mar
7-Mar

11-Apr
16-Apr
21-Apr
26-Apr

11-May

10-Jun
15-Jun
20-Jun
25-Jun
30-Jun

10-Jul
15-Jul
12-Mar
17-Mar
22-Mar
27-Mar

16-May
21-May
26-May
31-May

Daily number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 2: Daily and cumulative number of cases reported in Indonesia, as of 15 July 2020.
Source of data

Disclaimer: The number of cases reported daily is not the number of persons who
contracted COVID-19 on that day; reporting of laboratory-confirmed results may take up
to one week from the time of testing. Therefore, caution must be taken in interpreting this
figure and the epidemiological curve for further analysis.

• As of 15 July, most confirmed cases were in East Java and Jakarta,

followed by South Sulawesi, Central Java, West Java, South Kalimantan
and South Sumatra. Java contributed to almost 60% of the total cases.
The cumulative number of confirmed COVID-19 cases by province is shown
in Fig. 3.

3
WHO Indonesia Situation Report - 16
who.int/indonesia
 East Java
Jakarta
South Sulawesi
Central Java
West Java
South Kalimantan
South Sumatra
North Sumatra
Papua
Bali
North Sulawesi
West Nusa Tenggara
Banten
Central Kalimantan
North Maluku
Maluku
Province

West Sumatra
East Kalimantan
Southeast Sulawesi
Gorontalo
Yogyakarta
West Kalimantan
Riau Islands
West Papua
Riau
North Kalimantan
Lampung
Central Sulawesi
Bangka Belitung Islands
Bengkulu
West Sulawesi
Aceh
Jambi
East Nusa Tenggara

0 2000 4000 6000 8000 10000 12000 14000 16000 18000 20000
Cumulative number of confirmed COVID-19 cases

Figure 3: Cumulative number of confirmed COVID-19 cases by province in Indonesia, as of 15 July 2020.
Source of data

Disclaimer: Data from Jakarta include patients isolated or hospitalized in Wisma Atlet (RSDC: Rumah Sakit
Darurat COVID-19), which is the biggest national makeshift hospital for COVID-19; some patients may not
be residents of Jakarta. The same may apply to other provinces.
4
WHO Indonesia Situation Report - 16
who.int/indonesia
 • On 11 July, WHO, the Directorate of Surveillance and Health Quarantine,
the National Institute of Health Research and Development (NIHRD), and
the COVID-19 Task Force had a meeting on optimizing testing capacity and
strengthening the surveillance system at the subnational level. The three
key recommendations were: (i) enhancing laboratory testing capacity; (ii)
calculating the number of suspected cases that need to be tested in each
district to meet the WHO target of testing 1 suspected case per 1 000
population per week; and (iii) improving contact tracing as part of the
COVID-19 response plan.

• As of 15 July, the daily number of specimens tested remains higher than

the number of suspected cases tested (Fig. 4). The Ministry of Health (MoH)
has adopted the updated WHO criteria on patient discharge (from ‘Clinical
management of COVID-19’ guidelines), in the fifth revision of the national
guidelines on COVID-19 prevention and control that were finalized on 13
July. Consequently, an improvement in the diagnosis of suspected COVID-
19 cases is expected, with a reduced gap between the numbers of
specimens and suspected cases tested. Details can be found in WHO
Situation Report 15 (page 5).

30000

25000

20000
Daily number

15000

10000

5000

0
2-Jul
4-Jul
6-Jul
8-Jul
2-Jun
4-Jun
6-Jun
8-Jun
1-May
3-May
5-May
7-May
9-May
11-May
13-May
15-May
17-May
19-May
21-May
23-May
25-May
27-May
29-May
31-May

10-Jun
12-Jun
14-Jun
16-Jun
18-Jun
20-Jun
22-Jun
24-Jun
26-Jun
28-Jun
30-Jun

10-Jul
12-Jul
14-Jul

Number of specimens tested Number of suspected cases tested

Figure 4: The number of specimens and the suspected COVID-19 cases tested in Indonesia,
from 01 May to 15 July 2020. Source of data

Disclaimer: Due to the transition to a new data management application, there may have been
reporting issues in timing. Therefore, on certain days the number of specimens tested is almost
the same as the number of suspected cases tested, which might not have been the situation.

5
WHO Indonesia Situation Report - 16
who.int/indonesia
EPIDEMIOLOGICAL CRITERIA TO ASSESS COVID-19 TRANSMISSION

Table 1: Assessment of epidemiological criteria for six provinces in Java for the
3-week period from 22 June to 12 July.
Province Decline in the number of Positivity rate Decrease in the
confirmed COVID-19 cases (%) over 2 number of
since the latest peak* weeks** confirmed and
probable case
deaths for the last 3
weeks***
Jakarta Latest peak last week More than 5% No
West Java Latest peak last week Not applicable No
Central Java Less than 50% Not applicable No
Yogyakarta Latest peak last week Not applicable No
East Java Latest peak last week Not applicable No
Banten More than 50% over the
Not applicable Yes
three-week period

*date of latest peak differs for each province (see Figs. 5 to 10 for details)
**positivity rate is calculated from 29 June to 12 July 2020 for Jakarta; none of the other
provinces have met the minimum surveillance benchmark (explained in criterion 2) and,
therefore, have not been considered for calculation (see Fig. 11 for details)
***decrease in deaths is calculated from 22 June to 12 July 2020 (see Fig. 12 for details)

Criterion 1: Decline of at least 50% over a 3-week period since the latest peak and
continuous decline in the observed incidence of confirmed and probable cases

• Banten is the only province in Java that has seen a decline in the number
of confirmed COVID-19 cases of at least 50% for three weeks since the
latest peak (Figs. 5 to 10).

6
WHO Indonesia Situation Report - 16
who.int/indonesia
 Jakarta
2400 16000
2200 14000

Cumulative number
2000
Weekly number

1800 12000
1600 10000
1400
1200 8000
1000 6000
800
600 4000
400 2000
200
0 0

Number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 5: Weekly and cumulative number of confirmed COVID-19 cases in Jakarta, as of 12

July 2020. Source of data

West Java
1600 6000
1400

Cumulative number
5000
Weekly number

1200
1000 4000
800 3000
600 2000
400
200 1000
0 0

Number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 6: Weekly and cumulative number of confirmed COVID-19 cases in West Java,
as of 12 July 2020. Source of data

7
WHO Indonesia Situation Report - 16
who.int/indonesia
 Yogyakarta
Central Java
1200 50 400 6000
45 350

Cumulative number
1000 5000

Cumulative number
40
Weekly number

Weekly number

300
800 35 4000
30 250
600 25 200 3000
400 20 150 2000
15
200 100 1000
10
5 50
0 0
0 0

11/05/20 -…
02/03/20 -…
09/03/20 -…
16/03/20 -…
23/03/20 -…
30/03/20 -…
06/04/20 -…
13/04/20 -…
20/04/20 -…
27/04/20 -…
04/05/20 -…

18/05/20 -…
25/05/20 -…
01/06/20 -…
08/06/20 -…
15/06/20 -…
22/06/20 -…
29/06/20 -…
06/07/20 -…
Number of confirmed COVID-19 cases
Number of confirmed COVID-19
Cumulative cases of confirmed
number Cumulative number
COVID-19 of confirmed COVID-19 cases
cases

Figure 7: Weekly and cumulative number of confirmed COVID-19 cases in Central Java,
as of 12 July 2020. Source of data

Yogyakarta
50 400
45 350

Cumulative number
40
Weekly number

35 300
30 250
25 200
20 150
15 100
10
5 50
0 0

Number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 8: Weekly and cumulative number of confirmed COVID-19 cases in Yogyakarta,

as of 12 July 2020. Source of data

8
WHO Indonesia Situation Report - 16
who.int/indonesia
 East Java
3000 18000
16000

Cumulative number
2500
Weekly number

14000
2000 12000
10000
1500
8000
1000 6000
4000
500
2000
0 0

Number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 9: Weekly and cumulative number of confirmed COVID-19 cases in East Java,
as of 12 July 2020. Source of data

Banten
250 1800
1600

Cumulative number
200
Weekly number

1400
1200
150 1000
100 800
600
50 400
200
0 0

Number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Figure 10: Weekly and cumulative number of confirmed COVID-19 cases in Banten,
as of 12 July 2020. Source of data

9
WHO Indonesia Situation Report - 16
who.int/indonesia
 Criterion 2: Less than 5% of samples positive for COVID-19, at least for the last 2
weeks, assuming that surveillance for suspected cases is comprehensive

• The percentage of positive samples can be interpreted only with

comprehensive surveillance and testing of suspected cases, in the order
of 1 per 1 000 population per week. The only province in Java that has
achieved this minimum case detection benchmark is Jakarta.

2.50 35.0%

30.0%
Suspected cases tested/1000 population/week

2.00

25.0%

1.50

Positivity rate
20.0%

Benchmark: One suspected case tested/1000 population/week 15.0%

1.00

10.0%

0.50
Threshold positivity rate <5%
5.0%

0.00 0.0%
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3
Jakarta West Java Central Java Yogyakarta East Java Banten
Weeks
Suspected cases tested/1000 population/week Positivity rate

Figure 11: Positivity rate of cases, and suspected cases tested per 1 000 population per week:
Week 1: 22/06/20 - 28/06/20; Week 2: 29/06/20 - 05/07/20; Week 3: 06/07/20 - 12/07/20

For surveillance purposes, positivity rate is calculated as the number of confirmed cases divided
by the number of people tested for diagnosis. Source of data: Jakarta, West Java, Central Java,
East Java, Yogyakarta, Banten.
10
WHO Indonesia Situation Report - 16
who.int/indonesia
 Criterion 3: Decline in the number of deaths among confirmed and probable cases
at least for the last 3 weeks

Jakarta West Java

150 10
8
100 95
114 6
87 2 9
50 4
44 2 4
20 23 2
0 0
22/06/20 - 29/06/20 - 06/07/20 - 22/06/20 - 29/06/20 - 06/07/20 -
28/06/20 05/07/20 12/07/20 28/06/20 05/07/20 12/07/20
Death-Confirmed-Case Death-PDP & ODP Death-Confirmed-Case Death-PDP Death-ODP

East Java Yogyakarta

600 30
500 41
9
400 20
300 387 14 247
200 65 10
4
100 135 161 195
0 0 0 0 1
22/06/20 - 29/06/20 - 06/07/20 - 22/06/20 - 29/06/20 - 06/07/20 -
28/06/20 05/07/20 12/07/20 28/06/20 05/07/20 12/07/20
Death-Confirmed-Case Death-PDP Death-ODP Death-Confirmed-Case Death-PDP Death-ODP

Banten Central Java

15 250
200
10
150 114 120
12 91
8 100
5
5 50 99 96
81
2 2 1
0 0
22/06/20 - 29/06/20 - 06/07/20 - 22/06/20 - 29/06/20 - 06/07/20 -
28/06/20 05/07/20 12/07/20 28/06/20 05/07/20 12/07/20
Death-Confirmed-Case Death-PDP Death-ODP Death-Confirmed-Case Death-PDP Death-ODP
11
WHO Indonesia Situation Report - 16
who.int/indonesia
Figure 12: Deaths among confirmed COVID-19 cases, patients under investigation
(PDP) and persons under observation (ODP) per week over the last 3 weeks from 29
June to 12 July 2020 in six provinces in Java. Source of data: Jakarta, West Java,
Central Java, East Java, Yogyakarta, Banten.

Disclaimer: The data are provisional. Only some provinces are reporting data on deaths
of PDP and ODP. There may be a discrepancy in the number of deaths of confirmed
COVID-19 cases between national and provincial data sources. Due to a change in the
method of data publication for Jakarta, the number of PDP and ODP deaths have
been merged.

• Deaths among patients under surveillance (PDP) have been substantially

higher than deaths among confirmed COVID-19 cases in most provinces in
Java (Fig. 12).

HEALTH SYSTEM CRITERIA TO ASSESS COVID-19 TRANSMISSION

• On 02 July, the Director General of Disease Prevention and Control, MoH,
the spokesperson for COVID-19, mentioned during a press conference that
the bed occupancy rate was 55% nationwide5. In some provinces, however,
it was much higher, for example 72% in East Java6. As the number of cases
continues to increase, as a precaution, quick actions need to be undertaken
so the health system can cope with new hospitalizations without being
overwhelmed while still maintaining the delivery of essential services. A
monitoring system that captures details of the hospital occupancy and
intensive care unit (ICU) admission rates due to COVID-19 needs to be
strengthened to facilitate a swift response. Provinces with high bed
occupancy rates should be alerted and requested to prepare a mitigation
plan to cope with a potential sudden surge. Preparations should include
ensuring sufficient staff, equipment and supportive care medicines in health
facilities, the establishment of field hospitals, an increase in bed allocations
and the repurposing of hospitals exclusively for COVID-19 care.

5
https://republika.co.id/berita/qcu4n6382/yurianto-baru-separuh-kapasitas-rs-covid19-digunakan
6
https://www.liputan6.com/news/read/4296977/gugus-tugas-covid-19-kapasitas-ruang-isolasi-pasien-
corona-jatim-masih-cukup
12
WHO Indonesia Situation Report - 16
who.int/indonesia
 PLANNING, RISK AND NEEDS ASSESSMENT
• WHO has been providing training to the Centre for Health Crisis
Management, MoH, on the Essential Supplies Forecasting Tool (ESFT)
since early April. The MoH convened a series of webinars from 08 to 10
July to mentor all provinces on ESFT to facilitate the estimation of needs
for supplies and human resources based on respective clinical attack rates.
As a result of WHO’s intensive knowledge transfer, the MoH trained the
provinces on ESFT independently, while WHO supported in answering
questions from the provinces during the webinars.

• On 13 July, the fifth revision of the national guidelines on COVID-19

prevention and control were finalized by the MoH. In addition to the revised
case definition and discharge criteria, the guidelines state the four
transmission scenarios (no case, sporadic case, cluster and community
transmission) and interventions needed as per the country context; the
indicators for adjusting public health measures; and the discontinued use
of rapid diagnostics tests (RDTs) for COVID-19 diagnostic purposes. From
15 to 21 July, WHO will support the MoH to disseminate the revised
guidelines to all provinces.

LABORATORY

• As reported by the government on 15 July, the number of persons tested

for COVID-19 with polymerase chain reaction (PCR) was 15 491 and the
cumulative number of persons tested was 657 655 (Fig.13).

20000 800000
Daily number

Cumulative number
15000 600000
10000 400000
5000 200000
0 0
5-Jul
7-Mar

1-Apr
6-Apr

5-Jun
1-May
6-May
11-Apr
16-Apr
21-Apr
26-Apr

31-May
12-Mar
17-Mar
22-Mar
27-Mar

11-May
16-May
21-May
26-May

10-Jul
15-Jul
10-Jun
15-Jun
20-Jun
25-Jun
30-Jun

Reporting date

Daily number of suspected COVID-19 cases tested with PCR

Cumulative number of suspected COVID-19 cases tested with PCR

Figure 13: Daily and cumulative number of suspected COVID-19 cases tested with
polymerase chain reaction (PCR) in Indonesia, as of 15 July 2020. Source of data
13
WHO Indonesia Situation Report - 16
who.int/indonesia
 CASE MANAGEMENT
• As of 15 July, the proportion of people that recovered among the total
confirmed cases was 48.8% (Fig. 14). As of the same date, there were
37 247 confirmed COVID-19 cases under care or in isolation7.
45000 60.0
Cummulative number

40000
50.0
35000

Percentage (%)
30000 40.0
25000
30.0
20000
15000 20.0
10000
10.0
5000
0 0.0

5-Jul
1-Apr
6-Apr

1-May
6-May

5-Jun
11-Apr
16-Apr
21-Apr
26-Apr

26-May
11-May
16-May
21-May

31-May

10-Jul
15-Jul
10-Jun
15-Jun
20-Jun
25-Jun
30-Jun
Cumulative number of recovered cases Percentage recovery

Figure 14: Cumulative number of recovered cases and percentage recovery

from COVID-19 in Indonesia, as of 15 July 2020. Source of data

INFECTION PREVENTION AND CONTROL (IPC)

• On 09 July, WHO published a scientific brief on ‘Transmission of SARS-

CoV-2: implications for infection prevention precautions’. This document is
being translated into Indonesian and will be widely disseminated and
published on the website to ensure that the public is well-informed in a
timely manner. It is an update to the scientific brief published on 29 March
and includes new scientific evidence available on the transmission of
SARS-CoV-2. The document reiterates the earlier set of recommendations
to prevent transmission, in addition to:

i. Use of fabric masks in specific situations, for example, in public

places where there is community transmission and where other
prevention measures, such as physical distancing, are not possible;

ii. Use of contact and droplet precautions by health workers caring for
suspected and confirmed COVID-19 patients and use of airborne
precautions when aerosol generating procedures are performed;

7
https://covid19.go.id/
14
WHO Indonesia Situation Report - 16
who.int/indonesia
 iii. Continuous use of a medical mask by health workers and caregivers
working in all clinical areas, during all routine activities throughout
the entire shift; and

iv. Avoiding crowded places, close-contact settings and confined and

enclosed spaces with poor ventilation and ensuring good
environmental ventilation in all closed settings and appropriate
environmental cleaning and disinfection.

RISK COMMUNICATION

• On 09 July, WHO participated in a meeting on improving the strategy for

risk communication and community engagement (RCCE), convened by the
National Board for Disaster Management (BNPB). There was a discussion
about public communication on categorizing districts/cities into ‘zones’: red,
orange, yellow and green. WHO highlighted that it is important to ensure
that people are aware that there is a possibility of COVID-19 transmission
within and among all zones.

• WHO is regularly sharing important health messages on the website and

social media platforms – Twitter and Instagram, and has recently published:

- Videos in Indonesian on the following:

▪ Seven steps to prevent the spread of COVID-19
▪ The science of COVID-19
▪ COVID-19 prevention in the workplace

- An infographic in English and Indonesian: “Is dexamethasone a

treatment for all COVID-19 patients?”

15
WHO Indonesia Situation Report - 16
who.int/indonesia
 MENTAL HEALTH AND PSYCHOSOCIAL SUPPORT (MHPSS)

• On 09 July, WHO, the MoH and the

University of Brawijaya had a virtual
discussion on the development of
video tutorials for volunteers and
responders at national and
subnational levels on appropriate
MHPSS services during the
pandemic. These videos will
incorporate technical aspects from
WHO guidance on psychological
first aid and stress management,
and the Inter-Agency Standing
Committee guidance on basic
psychosocial skills.

Figure 15: A snapshot of the WHO

guidance on psychological first aid
translated in Indonesian, available online.

CONTINUITY OF ESSENTIAL HEALTH SERVICES

• On 09 July, WHO participated in a technical meeting with the MoH on the

preparation of a series of video conferences on leptospirosis control during
the pandemic. Early symptoms of leptospirosis are very similar to
COVID-19. These video conferences, scheduled from late July to mid-
August, will aim to improve awareness of healthcare workers on
leptospirosis detection and treatment during the COVID-19 pandemic as
well as communicate preventive measures for both diseases.

• WHO is supporting the government with programme analysis of various

essential health services to maintain their continuity during the pandemic.
Highlights of the HIV programme are presented below.

Impact of COVID-19 on the National AIDS Programme (NAP) in Indonesia:

i. HIV testing has significantly decreased nationwide in April and May 2020
compared to the same period in 2019. Number of tests per month have

16
WHO Indonesia Situation Report - 16
who.int/indonesia
 declined by almost 50.0% and 60.0% in April and May 2020, respectively,
compared to the same months in 2019 (Fig.16).

400000
350000 340656 336069
333796 308204
300000
Number of HIV tests

250000
200000 172302
150000 124113
100000
50000
0
March April May

2019 2020

Figure 16: Number of HIV tests performed from March to May 2019 vs. 2020.
Source: National AIDS Programme, Ministry of Health, Indonesia, unpublished data

ii. Similarly, between March and May this year, the number of people living
with HIV (PLHIV) entering HIV care and initiating antiretroviral treatment
(ART) has fallen to nearly half the number that were enrolled the same
months last year (Fig. 17).

iii. HIV and syphilis testing among pregnant women, which is significant for the
prevention of mother-to-child transmission, has declined during the COVID-
19 pandemic (Fig. 18).

iv. The Jaringan Indonesia Positif (JIP or Indonesian Positive Network)

conducted a rapid survey in March 2020 on the needs of PLHIV in the
context of COVID-19. The results showed that 89.4% received enough
medication for an entire month, while only 2.3% of the patients had to visit
the health facilities more than once a month, i.e. there was enough
antiretrovirals (ARV) stock in March. Another round of the survey is being
planned to assess any disruption in ARV stock availability.

17
WHO Indonesia Situation Report - 16
who.int/indonesia
 5000
4500
4000

Number of patients
3500
3000
2500
2000
1500
1000
500
0
March April May
Enrolled in HIV care 2019 4358 4382 4251
Enrolled in HIV care 2020 4757 3349 2961
Initiated ART 2019 2936 3290 3019
Initiated ART 2020 3471 2325 1547
Figure 17: Trend of enrollment in HIV care and initiation of ART from March to May 2019 vs. 2020.
Source: National AIDS Programme, Ministry of Health, Indonesia, unpublished data

250000 236584
222316 226792 220054 223500
203994 202852 204605
200000
Number

150755
150000
109707
100000 81714

47011 49184
50000 39349 37914 41682 42102 38024 42059
30240
22999 18066

0
Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 May-20
Pregnant women tested for HIV Pregnant women tested for syphilis

Figure 18: Trend of pregnant women tested for HIV and syphilis from July 2019 to May 2020.
Source: National AIDS Programme, Ministry of Health, Indonesia, unpublished data

18
WHO Indonesia Situation Report - 16
who.int/indonesia
To mitigate the impact of COVID-19 and maintain essential HIV services,
interventions are being carried out in the following areas:
i. Guideline: On 02 April, the MoH issued a protocol on HIV/AIDS service
delivery during the pandemic, in line with the WHO guidance on ‘Maintaining
essential health services: operational guidance for the COVID-19 context’.
The protocol advises, for instance, to increase awareness and practice of
infection prevention and control measures; to ensure the continuity of ART
for PLHIV by provision of multi-month ARV to last two to three months; offer
home delivery of ARV to reduce health facility visits; and to improve
collaboration with community and civil society organizations (CSOs) to
ensure retention of HIV care and avoid loss-to-follow-up for PLHIV.

ii. Surveillance: Routine HIV and sexually transmitted disease (STD)

recording and reporting from health facilities are continuing in parallel with
regular updates on SIHA (HIV-AIDS Information System). The NAP initiated
a survey for health facilities (hospitals and puskesmas) and District and
Province Health Offices to assess COVID-19 impacts on HIV services
including on human resources, test and treatment, logistics and laboratory.

iii. Diagnosis: Testing services in health facilities are ongoing, while mobile
testing services have been put on hold. A project on HIV self-testing for key
populations has been initiated in 25 districts, in collaboration with CSOs.
HIV self-testing is expected to increase testing, particularly among key
populations who are otherwise unlikely to visit health facilities.

Figure 19: Testing for HIV and other sexually transmitted diseases should continue
alongside the COVID-19 response, adhering to proper infection prevention and
control protocols. Credit: WHO
19
WHO Indonesia Situation Report - 16
who.int/indonesia
 iv. Logistics: The policy on multi-month dispensing of ARV was introduced in
the protocol of HIV/AIDS service delivery during the COVID-19 pandemic.
Two to three months of ARV stocks may be provided to patients to reduce
the frequency of visits to health facilities. ARV stocks have been secured
through national sources. The MoH has requested the procurement of
personal protective equipment for health facilities, outreach workers and
peers through the Global Fund.

v. Human resources: WHO and the MoH are conducting webinars to increase
awareness on COVID-19 in health facilities and among outreach workers
and peers. The NAP has adapted trainings to webinars to continue capacity
building of human resources as planned.

vi. Prevention: Outreach workers and peers continue to support HIV key
populations and PLHIV through online platforms (WhatsApp, various CSO
websites, Line, WeChat, etc.).

PARTNER COORDINATION

• On 11 July, WHO participated in the Humanitarian Country Team meeting

and presented on the global and national situations of the pandemic and
highlighted the WHO guidance on the Strategic Preparedness and
Response Plan (SPRP) to support COVID-19 response planning,
particularly at subnational levels, given the vast diversity of the archipelago.
WHO emphasized the importance of cross-sectoral participation of other
UN agencies that have staff working at the subnational levels to support in
implementing the provincial response plans.

• Overall funding request for WHO operations and technical assistance is

US$ 46 million (27 million for response and 19 million for recovery phase),
based on estimated needs as of July 2020 (Fig. 20).

20
WHO Indonesia Situation Report - 16
who.int/indonesia
 Figure 20: WHO funding situation for COVID-19 response, July 2020

Data presented in this situation report have been taken from publicly available data from the MoH
(https://infeksiemerging.kemkes.go.id/), BNPB (http://covid19.go.id) and provincial websites. There
may be differences in national and provincial data depending on the source used. All data are
provisional and subject to change.

21
WHO Indonesia Situation Report - 16
who.int/indonesia
A SNAPSHOT OF WHO COURSES AND INFORMATION MATERIAL

Online WHO COVID-19 courses:

• Operational planning guidelines and COVID-19
• Clinical management of severe acute respiratory infections
• Health and safety briefing for respiratory diseases – eProtect
• Infection prevention and control
• Emerging respiratory viruses, including COVID-19
• Design of severe acute respiratory infection treatment facility

WHO guidance:
• Doing things that matter
• Considerations for school-related public health measures
• Cleaning and disinfection of environmental surfaces
• Guiding principles for immunization activities during the COVID-19
pandemic
• Maintaining a safe and adequate blood supply during the COVID-19
pandemic
• Advice for the use of immunodiagnostics tests (point-of-care) in health
facilities

Infographics:
• The ‘new normal’
• Science solutions solidarity
• Helping the elderly
• The ‘new normal’
• Domestic violence
• Staying healthy in the workplace
• Quarantine and self-monitoring
• Mental health
• Keep cool – health advice in hot weather
• Physical distancing is not social isolation
• A selection of myth-busters

Videos:
• How to use medical masks
• How to use fabric masks
• Who wears what mask when
• How has WHO responded to COVID-19
• Myth-buster: ‘Can shoes spread COVID-19?’
• Breastfeeding and COVID-19
• Depression due to COVID-19

For more information please feel free to contact: seinocomm@who.int

WHO Indonesia Reports

22
WHO Indonesia Situation Report - 16
who.int/indonesia